Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice
Authors:
Open Access
- 29 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 14, 1004557
Abstract
Although diabetic cognitive impairment is one of the most common complications of type 2 diabetes mellitus (T2DM), optimized therapeutic strategies are not available yet. Astragalosides IV (AS-IV) is a traditional Chinese medicine possessing diverse pharmacological properties including anti-inflammatory and antioxidant effects. However, the effects of AS-IV on diabetes-related cognitive impairment and its precise mechanisms remain largely unknown. T2DM mice, induced by a high-fat diet (HFD) and an intraperitoneal injection of low-dose streptozotocin (STZ) were administrated with AS-IV every other day for eight consecutive weeks. Learning and memory abilities were assessed subsequently using the Ymaze test and the anxious behavior was evaluated using an open field test. Then, the morphology and number of neurons and microglia were observed by HE staining or immunohistochemistry. Oxidative stress biomarkers and pro-inflammatory cytokines were determined using relevant kits. In addition, the expression levels of Nrf2, Keap1, HO-1, and NQO1 were determined by Western blot analyses. The results indicated that AS-IV administration significantly improved neuronal damage and cognitive deficit in T2DM mice. Meanwhile, oxidative stress and neuroinflammation were also ameliorated in T2DM mice, which might be attributed to the regulation of Nrf2/Keap1/HO-1/NQO1 pathway in T2DM mice. Taken together, these data suggested that AS-IV ameliorates cognitive impairment in T2DM mice by attenuating oxidative stress and neuroinflammation, possibly through modulating the Nrf2/Keap1/HO1/NQO1 pathway.Keywords
This publication has 40 references indexed in Scilit:
- Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in RatsMolecules, 2015
- Astragaloside IV Inhibits NF‐κB Activation and Inflammatory Gene Expression in LPS‐Treated MiceMediators of Inflammation, 2015
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expressionCytokine, 2013
- Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathwaysApoptosis, 2013
- Role of Nrf2 in Oxidative Stress and ToxicityAnnual Review of Pharmacology and Toxicology, 2013
- Risk of Hypoglycemia in Older Veterans with Dementia and Cognitive Impairment: Implications for Practice and PolicyJournal of the American Geriatrics Society, 2011
- Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 DiabetesDiabetes, 2009
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Risk of dementia in diabetes mellitus: a systematic reviewThe Lancet Neurology, 2006
- Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative diseaseProgress in Neurobiology, 2005